ArticleRadiology case reports2026
Intravenous leiomyomatosis: A retrospective case series of imaging findings and diagnostic challenges.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravenous leiomyomatosis (IVL) is a rare entity with nonspecific presentations, often leading to diagnostic challenges. Complete surgical resection requires precise preoperative imaging to map tumor extent. This retrospective case series summarized the imaging characteristics of 19 IVL cases and 1 endometrial stromal sarcoma (ESS) initially misdiagnosed as IVL, and compared the diagnostic utility of CT, MRI, and ultrasound. Among the 19 IVL cases, 7 were stage I, 5 stage II, 3 stage III, and 4 stage IV. Nearly half (47.3%) were asymptomatic, and 11 cases (57.9%) experienced initial missed or misdiagnosis. Only 3 cases demonstrated the typical worm-like extension of uterine fibroids into the parauterine veins. Pelvic lesions were categorized as solid (9 cases), predominantly solid (7 cases), or predominantly cystic (2 cases), with the latter considered atypical. Sixteen patients underwent enhanced CT/MRI; 2 presented with multilocular cystic masses consistent with ultrasound findings, while the remaining 14 exhibited uterine or pelvic soft tissue masses with heterogeneous density and mild-to-moderate enhancement. Enhanced MRI uniquely delineates pathognomonic worm-like contours and parametrial venous filling defects. For intravascular lesions, CT venous-phase imaging most clearly defined tumor extent, with both uterine and ovarian vein involvement being most common (47.4%, 9/19). Fourteen cases (73.7%) showed solid-density intravascular lesions, while 4 (21.1%) exhibited an atypical "sieve-like" pattern. The one ESS case had imaging features resembling IVL but showed significantly elevated PET-CT metabolic activity and CA125 levels. Ultrasound combined with CT/MRI enables comprehensive IVL evaluation. We recommend analyzing both pelvic and intravascular components, with attention to atypical manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.